Annual Current Assets
$644.96 M
+$44.66 M+7.44%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual total current assets is $644.96 million, with the most recent change of +$44.66 million (+7.44%) on December 31, 2023.
- During the last 3 years, XENE annual current assets has risen by +$463.18 million (+254.80%).
- XENE annual current assets is now at all-time high.
Performance
XENE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$659.64 M
-$68.45 M-9.40%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly total current assets is $659.64 million, with the most recent change of -$68.45 million (-9.40%) on September 30, 2024.
- Over the past year, XENE quarterly current assets has dropped by -$68.45 million (-9.40%).
- XENE quarterly current assets is now -17.01% below its all-time high of $794.80 million, reached on June 30, 2022.
Performance
XENE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
XENE Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.4% | -9.4% |
3 y3 years | +254.8% | +21.1% |
5 y5 years | +431.6% | +21.1% |
XENE Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +15.4% | -17.0% | +24.2% |
5 y | 5-year | at high | +345.2% | -17.0% | +355.3% |
alltime | all time | at high | +1339.0% | -17.0% | +1699.3% |
Xenon Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $659.64 M(-9.4%) |
Jun 2024 | - | $728.09 M(+3.0%) |
Mar 2024 | - | $707.20 M(+9.7%) |
Dec 2023 | $319.84 M(+107.9%) | $644.96 M(+21.5%) |
Sep 2023 | - | $531.01 M(-2.5%) |
Jun 2023 | - | $544.62 M(+2.1%) |
Mar 2023 | - | $533.35 M(-11.2%) |
Dec 2022 | $153.85 M(+1084.6%) | $600.30 M(-7.5%) |
Sep 2022 | - | $649.18 M(-18.3%) |
Jun 2022 | - | $794.80 M(+45.7%) |
Mar 2022 | - | $545.62 M(-2.4%) |
Dec 2021 | $12.99 M(+75.4%) | $559.02 M(+118.1%) |
Sep 2021 | - | $256.31 M(-3.9%) |
Jun 2021 | - | $266.75 M(-5.8%) |
Mar 2021 | - | $283.26 M(+55.8%) |
Dec 2020 | $7.40 M(+161.5%) | $181.78 M(-6.7%) |
Sep 2020 | - | $194.81 M(-5.9%) |
Jun 2020 | - | $207.01 M(-11.5%) |
Mar 2020 | - | $233.87 M(+61.4%) |
Dec 2019 | $2.83 M | $144.87 M(+50.2%) |
Sep 2019 | - | $96.48 M(-6.6%) |
Jun 2019 | - | $103.33 M(-7.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $112.05 M(-7.7%) |
Dec 2018 | $1.10 M(-15.7%) | $121.33 M(-6.3%) |
Sep 2018 | - | $129.49 M(+101.2%) |
Jun 2018 | - | $64.35 M(+75.5%) |
Mar 2018 | - | $36.66 M(-18.2%) |
Dec 2017 | $1.30 M(-28.3%) | $44.82 M(-0.4%) |
Sep 2017 | - | $44.99 M(-14.5%) |
Jun 2017 | - | $52.63 M(-11.0%) |
Mar 2017 | - | $59.14 M(-9.9%) |
Dec 2016 | $1.81 M(-41.2%) | $65.67 M(-8.0%) |
Sep 2016 | - | $71.35 M(+33.6%) |
Jun 2016 | - | $53.39 M(-8.4%) |
Mar 2016 | - | $58.27 M(-4.3%) |
Dec 2015 | $3.08 M(+24.5%) | $60.87 M(-7.9%) |
Sep 2015 | - | $66.11 M(-11.1%) |
Jun 2015 | - | $74.35 M(-3.5%) |
Mar 2015 | - | $77.05 M(-9.3%) |
Dec 2014 | $2.48 M(-46.4%) | $84.94 M(+76.0%) |
Sep 2014 | - | $48.27 M(+6.8%) |
Jun 2014 | - | $45.21 M(-9.3%) |
Dec 2013 | $4.62 M(+77.5%) | $49.87 M |
Dec 2012 | $2.60 M | - |
FAQ
- What is Xenon Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual current assets year-on-year change?
- What is Xenon Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly current assets year-on-year change?
What is Xenon Pharmaceuticals annual total current assets?
The current annual current assets of XENE is $644.96 M
What is the all time high annual current assets for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual total current assets is $644.96 M
What is Xenon Pharmaceuticals annual current assets year-on-year change?
Over the past year, XENE annual total current assets has changed by +$44.66 M (+7.44%)
What is Xenon Pharmaceuticals quarterly total current assets?
The current quarterly current assets of XENE is $659.64 M
What is the all time high quarterly current assets for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly total current assets is $794.80 M
What is Xenon Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, XENE quarterly total current assets has changed by -$68.45 M (-9.40%)